(4R,5R,6R,7R)-4,7-DIBENZYLOXYMETHYL-5,6-DIHYDROXY-5,6-O-METHYLETHYLIDENE-2-(N-BENZYL)-IMINO-1,3-DIAZEPANE
Compound with spectra: 1 NMR
| SpectraBase Compound ID | 8vRtHgLQdck |
|---|---|
| InChI | InChI=1S/C31H37N3O4/c1-31(2)37-28-26(21-35-19-24-14-8-4-9-15-24)33-30(32-18-23-12-6-3-7-13-23)34-27(29(28)38-31)22-36-20-25-16-10-5-11-17-25/h3-17,26-29H,18-22H2,1-2H3,(H2,32,33,34)/t26-,27-,28-,29-/m1/s1 |
| InChIKey | DDKSZXDHGIGPSQ-CXDXLJMYSA-N |
| Mol Weight | 515.7 g/mol |
| Molecular Formula | C31H37N3O4 |
| Exact Mass | 515.278407 g/mol |
| Enantiomer InChIKey | DDKSZXDHGIGPSQ-DZUOILHNSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(4S,5R,6R,7S)-4,7-DIBENZYLOXYMETHYL-5,6-DIHYDROXY-5,6-O-METHYLETHYLIDENE-2-(N-BUTYL)-IMINO-1,3-DIAZEPANE
(4R,5R,6R,7R)-4,7-DIBENZYLOXYMETHYL-5,6-DIHYDROXY-2-METHYLTHIO-4,5,6,7-TETRAHYDRO-1,3-DIAZEPINIUM-PARA-TOLUENE-SULFONATE
(3aS,4S,5R,7aR)-(5-hydroxy-2,2-dimethylhexahydrobenzo[1,3]dioxol-4-yl)carbamic acid methyl ester
2-AMINO-2-DEOXY-1,2-O,N-ETHYLENE-3,4-O-ISOPROPYLIDENE-BETA-L-RIBOPYRANOSE
1,3,4,5-TETRA-O-BENZYL-2,6-DIDEOXY-2,6-IMINO-L-GLYCERO-L-GALACTO-HEPTITOL
[(3aR,5S,6R,6aR)-2,2-dimethyl-6-(oxidanylamino)-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]dioxol-5-yl]methyl benzoate
(-)-6-O-Benzyl-1-deoxy-1-(dimethylphosphono)-3,4-O-isopropylidene-D-ribo-hexulose
(1R)-1-[(3aS,4S,6R,6aS)-4-methoxy-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]-2-benzoxy-ethanol
Methyl 2,3,4,6-tetra-O-benzylhexopyranoside
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of C 2 -symmetric guanidino-sugars as potent inhibitors of glycosidases | Bioorganic & Medicinal Chemistry | 2000 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.